| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/07/2006 | US20060275913 Carbonyl compound scavenger and method of quantifying carbonyl compound using the same |
| 12/07/2006 | US20060275912 Fluorescent probes |
| 12/07/2006 | US20060275911 Method and apparatus for moleclular analysis using nanostructure-enhanced Raman spectroscopy |
| 12/07/2006 | US20060275910 Misfolded protein sensor method in body fluids |
| 12/07/2006 | US20060275909 Nutrition formulations and methods of providing nutrition formulations |
| 12/07/2006 | US20060275908 Control value assignment method |
| 12/07/2006 | US20060275907 including a measuring chamber through which the medium can flow and which has at least one elastically deformable wall, at least one wall that is more rigid by comparison to the elastically deformable wall, and an inlet and outlet for the medium, an excitation electrode is provided |
| 12/07/2006 | US20060275898 Compositions and Methods for Making Embryonic Stem Cells |
| 12/07/2006 | US20060275892 Reaction vessel, reaction apparatus and detection apparatus using the same, and method of manufacturing reaction vessel |
| 12/07/2006 | US20060275876 Use of selective labeling to detect and characterize molecular interactions by nuclear magnetic resonance spectroscopy |
| 12/07/2006 | US20060275871 encoding mammalian Ca2+/calmodulin stimulated phosphodiesterases (CaM-PDEs) and cyclic-GMP-stimulated phosphodiesterases (cGS-PDEs); drug screening to identify compounds which modulate the enzymatic activity of expression products |
| 12/07/2006 | US20060275870 Novel G-protein coupled receptors and uses therefor |
| 12/07/2006 | US20060275856 Method for analyzing cell free notch cleavage and method for drug screening |
| 12/07/2006 | US20060275855 Enzyme array and assay |
| 12/07/2006 | US20060275853 Methods to increase dynamic range and improve quantitative analysis in rapid biosensors |
| 12/07/2006 | US20060275852 Assays based on liquid flow over arrays |
| 12/07/2006 | US20060275851 Layered peptide/antigen arrays - for high-throughput antibody screening of clinical samples |
| 12/07/2006 | US20060275850 Immunological assay and antibodies for Anti-Mullerian Hormone |
| 12/07/2006 | US20060275849 Monoclonal antibody reagents |
| 12/07/2006 | US20060275848 Diagnosis and treatment of microbacterial infections |
| 12/07/2006 | US20060275847 Method for assessing biofilms |
| 12/07/2006 | US20060275846 Detection of antigen specific immunocomplexes |
| 12/07/2006 | US20060275845 Diagnosing cancer in humans; obtain sample, detect annexin protein in sample, amplified concentration of annexins indicates cancer |
| 12/07/2006 | US20060275844 Diagnostic markers of breast cancer treatment and progression and methods of use thereof |
| 12/07/2006 | US20060275843 Methods for diagnosing the presence or stage of cancer |
| 12/07/2006 | US20060275842 Methods and kits useful for the simplification of complex peptide mixtures |
| 12/07/2006 | US20060275841 Assay method and apparatus with reduced sample matrix effects |
| 12/07/2006 | US20060275840 Support and method for cell based assays |
| 12/07/2006 | US20060275839 Genes |
| 12/07/2006 | US20060275838 Compositions and methods for inhibiting liver stellate cell growth |
| 12/07/2006 | US20060275837 At least one cysteine is replaced with seleno-cysteine or methyl-seleno-cysteine is covalently bonded to the first amino acid in the sequence; selenium analogs of the small molecule dofetilide; the peptide BeKm-1 |
| 12/07/2006 | US20060275836 Methods of identifying respondents to hypoxia inducible factor 1-alpha inhibitors |
| 12/07/2006 | US20060275835 Methods for identifying cell surface receptor protein modulators |
| 12/07/2006 | US20060275834 Methods and compositions related to joint inflammation diseases |
| 12/07/2006 | US20060275833 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 12/07/2006 | US20060275832 Methods of screening cyclic peptides and identifying targets therefor |
| 12/07/2006 | US20060275831 Complement C3 precursor biopolymer markers predictive of type II diabetes |
| 12/07/2006 | US20060275830 Isolating nucleic acid encoding a plant polypeptide for use in generating disease resistant plants; obtain library, incubate with probe, recover clone, transform plant, propagate, evaluate for disease resistance |
| 12/07/2006 | US20060275828 Use of a fluorescent protein for detecting interactions between a target protein and its ligand |
| 12/07/2006 | US20060275827 non-oligomerizing Clavularia teal fluorescent protein (TFP) variant having a tyrosine-derived chromophore; nucleic acid compatible with mammalian codon usage |
| 12/07/2006 | US20060275826 Artificial antibody comprising complementary peptide |
| 12/07/2006 | US20060275825 Proteolipid membrane and lipid membrane biosensor |
| 12/07/2006 | US20060275823 Selection of peptides with antibody-like properties |
| 12/07/2006 | US20060275822 Fluorescent indicator using fret |
| 12/07/2006 | US20060275821 Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 12/07/2006 | US20060275820 Multiplex flow assays preferably with magnetic particles as solid phase |
| 12/07/2006 | US20060275818 Method of producing probe arrays for biological materials using fine particles |
| 12/07/2006 | US20060275807 Novel steroid 5alpha-reductase |
| 12/07/2006 | US20060275804 Enzymes having dehalogenase activity and methods of use thereof |
| 12/07/2006 | US20060275803 Rat and mouse members of the CRISP family of genes |
| 12/07/2006 | US20060275801 Type II diabetes; immunoassay; noninvasive ; Efficient |
| 12/07/2006 | US20060275800 Process for characterization of the transactivation and transrepression activity of glucocorticoid receptor ligands in primary immune cells |
| 12/07/2006 | US20060275791 Biological control of nanoparticle nucleation, shape and crystal phase |
| 12/07/2006 | US20060275789 Direct multiplex characterization of genomic DNA |
| 12/07/2006 | US20060275787 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules |
| 12/07/2006 | US20060275783 Gene markers for lung cancer |
| 12/07/2006 | US20060275772 Nucleic acid probe of which end is labeled with a fluorescent dye, and in which fluorescence of the fluorescent dye decreases upon hybridization; mutation is detected on the basis of the result of the melting curve analysis |
| 12/07/2006 | US20060275771 Quantitative reagent, method and equipment of substance utilizing fluorescence lifetime |
| 12/07/2006 | US20060275770 Heart failure gene determination and therapeutic screening |
| 12/07/2006 | US20060275768 Multiplex polymer ligation |
| 12/07/2006 | US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders |
| 12/07/2006 | US20060275757 Magnetic nanomaterials and methods for detection of biological materials |
| 12/07/2006 | US20060275756 Displacement assay for detecting ligate-ligand association events |
| 12/07/2006 | US20060275755 Novel nucleic acids and polypeptides related to a guanine exchange factor of rho gtpase |
| 12/07/2006 | US20060275754 Method for a rapid test |
| 12/07/2006 | US20060275753 Recovery of analytes using combinatorial libraries |
| 12/07/2006 | US20060275752 Multiparameteric method for assessing immune system status |
| 12/07/2006 | US20060275750 Bioreactive agents |
| 12/07/2006 | US20060275746 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 12/07/2006 | US20060275330 Pygopus in diagnosis and treatment of cancer |
| 12/07/2006 | US20060275329 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnostic |
| 12/07/2006 | US20060275327 In vivo modulation of neuronal transport |
| 12/07/2006 | US20060275323 Particles of HCV envelope proteins: use for vaccination |
| 12/07/2006 | US20060275320 Providing a polypeptide having the N-terminal domain of the long form phosphotransacetylase;exposing the polypeptide to a test agent; determining whether the agent binds to the N-terminal domain; binding indicates agent is likely to have virulence-attenuating activity |
| 12/07/2006 | US20060275319 Saccharomyces cerevisiae yeast strain with functional expression of a GLUT transporter |
| 12/07/2006 | US20060275318 Surface protein of leptospira |
| 12/07/2006 | US20060275317 Vaccine compositions for prevention of chronic and infectious diseases |
| 12/07/2006 | US20060275314 Transmembrane protein differentially expressed in cancer |
| 12/07/2006 | US20060275313 Therapeutic and diagnostic agents |
| 12/07/2006 | US20060275312 Molecule |
| 12/07/2006 | US20060275310 Method and detection and decontamination of antigens by nanoparticle-raman spectroscopy |
| 12/07/2006 | US20060275307 Antibodies to treat cancer |
| 12/07/2006 | US20060275304 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 12/07/2006 | US20060275300 P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof |
| 12/07/2006 | US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
| 12/07/2006 | US20060275289 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 12/07/2006 | US20060275287 Scroll compressor |
| 12/07/2006 | US20060275286 Monoclonal antibody named KIS-1N produced by the hybridoma cell line; for development of an agent for the diagnosis and prevention/treatment of diseases (cancer, and so forth) associated with the polypeptide |
| 12/07/2006 | US20060275285 Methods of inhibiting a GPCR |
| 12/07/2006 | US20060275277 Use of coagulation proteins to lyse clots |
| 12/07/2006 | US20060275274 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome |
| 12/07/2006 | US20060275266 Tripeptide of FcyRIIA |
| 12/07/2006 | US20060275258 Interferon-alpha induced gene |
| 12/07/2006 | US20060275255 NF-kappa B modulators; for protecting mammals from ionizing radiation sufficient to cause gastrointestinal syndrome or hematopoietic syndrome via administering recombinant flagellin |
| 12/07/2006 | US20060275214 Methods of screening for anti-inflammatory drugs and use thereof |
| 12/07/2006 | US20060275212 Treatment and diagnosis of cancer |
| 12/07/2006 | US20060275211 Antibodies and related molecules that bind to 161P2F10B proteins |
| 12/07/2006 | US20060275210 inhibit proliferation of CK-B4 expression; used to diagnose, treat, prevent cancer, to inhibit the progression or metastasis of myeloproliferative and other disorders such as leukemia, T-cell lymphoma, and/or B-cell lymphoma |
| 12/07/2006 | US20060275174 Transportable measuring apparatus utilizing hydrogen flame |
| 12/07/2006 | US20060272942 Electrochemical microfluidic sensor and method of creation of its microchannels by embossing |